Atherogenics Inc. (AGIXQ) Stock Quote

Detailed Quote for Atherogenics Inc. (AGIXQ)

close 52 Week Information

52 Week High

Close: N/A

52 Week Low

Close: N/A

Today

Last Price
N/A

Change $
N/A

Change %
N/A

Tick
N/A

Bid
N/A

Bid Size
N/A

Ask
N/A

Ask Size
N/A

Open
N/A

High
N/A

Low
N/A

Prev Close
N/A

Last Trade
N/A

Volume
0

52 Wk Hi
N/A

52 Wk Low
N/A

Market Cap
N/A

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
39,518,492

EPS (TTM)
N/A

PE Ratio
N/A

close Exchange Information Listed On OTC Pink (OTCPK) Exchange
OTCPK

News and Media for Atherogenics Inc. (AGIXQ)

Sector News | Topic News

News for AGIXQ

Thu, Mar 02, 2006

1:29 PM

AtheroGenics Announces March 2006 Investor Conference Presentation Schedule - Canada Newswire

Tue, Feb 28, 2006

7:00 AM

AtheroGenics Reports Fourth Quarter and Year-End 2005 Financial Results - Canada Newswire

Wed, Feb 15, 2006

11:39 AM

AtheroGenics Schedules 2005 Fourth Quarter and Year-End Results Conference Call for February 28, 2006 - Canada Newswire

Tue, Feb 07, 2006

7:02 AM

AtheroGenics to Present at the BIO CEO & Investor Conference on February 14, 2006 - Canada Newswire

Thu, Feb 02, 2006

7:05 AM

AtheroGenics Extends Research and Development Collaboration with Astellas Pharma Inc. - Canada Newswire

Mon, Jan 30, 2006

7:15 AM

AtheroGenics and AstraZeneca Development and Commercialization Agreement for AGI-1067 Completes Early Hart-Scott-Rodino Review - Canada Newswire

Wed, Jan 04, 2006

10:01 AM

AtheroGenics to Present at 24th Annual JPMorgan Healthcare Conference - Canada Newswire

Thu, Dec 22, 2005

9:33 AM

AtheroGenics and AstraZeneca Announce Late Stage License and Commercialization Agreement for Novel Atherosclerosis Drug AGI-1067 - Canada Newswire

Thu, Dec 08, 2005

8:14 AM

AtheroGenics CEO to Present at Adams Harkness' Inflammatory Disease Company Showcase & Panel Discussion on December 14, 2005 - Canada Newswire

Mon, Nov 21, 2005

2:48 PM

AtheroGenics to Present at Lazard Capital Markets Annual Life Sciences Conference on November 29, 2005 - Canada Newswire

Thu, Oct 20, 2005

8:39 AM

AtheroGenics Reports Third Quarter 2005 Financial Results - Canada Newswire

Mon, Oct 03, 2005

10:35 AM

AtheroGenics Sets Date for Third Quarter 2005 Results - Canada Newswire

Wed, Aug 31, 2005

11:44 AM

AtheroGenics to Present at the Thomas Weisel Partners 2005 Healthcare Conference on September 8, 2005 - Canada Newswire

Tue, Jul 26, 2005

11:05 AM

AtheroGenics to Present at the Adams Harkness 25th Annual Summer Seminar on August 3, 2005 - Canada Newswire

Thu, Jul 21, 2005

7:35 AM

AtheroGenics Reports Second Quarter 2005 Financial Results - Canada Newswire

Wed, Jul 06, 2005

8:05 AM

AtheroGenics to Report Second Quarter 2005 Results on July 21, 2005 - Canada Newswire

Tue, Jul 05, 2005

10:20 AM

AtheroGenics Appoints Joseph M. Gaynor, Jr., Vice President and General Counsel - Canada Newswire

Thu, Jun 30, 2005

7:05 AM

AtheroGenics Schedules Conclusion of Patient Screening in Pivotal Phase III ARISE Trial - Canada Newswire

Fri, Jun 17, 2005

11:40 AM

AtheroGenics Resale Registration Statement on Form S-3 Declared Effective - Canada Newswire

Wed, Jun 01, 2005

4:14 PM

AtheroGenics to Present at the 7th Annual Thomas Weisel Partners Growth Forum on June 13, 2005 - Canada Newswire

More News for AGIXQ >>

Tags for Atherogenics Inc.

Research stocks or mutual funds related to Atherogenics Inc. by keywords or tags. Find companies that have a similar focus to AGIXQ. The keywords below have been associated to AGIXQ by either user submission or electronic means.